Emphysema after Sinus Grafting: Importance of Patient's Information, Early Diagnosis, and Management.

The sinus elevation procedure is a safe and predictable technique that allows the placement of implants in atrophic posterior maxillae. However, some recommendations have to be followed by the patient to ensure reliable healing. It is particularly important to avoid inducing trauma in the region concerned and through the sinuses. This report describes a rare complication that occurred after the grafting of a sinus, which was attributed to a violent sneeze a few hours after the intervention. The diagnosis of emphysema following air entry was confirmed by the suddenness of the swelling and associated crepitation, and by the radiographic observation of a delimited radiolucent zone in the grafted sinus. The immediate diagnosis and subsequent management prevented further adverse events. This case report supports the need for complete comprehensive instruction of patients after oral surgery, swift diagnosis, and management of emphysema.

Development of a surgical guide for minimally invasive corticotomies with a complete digital intraoral and laboratory workflow.

AIM: Surgically facilitated orthodontic treatment is increasingly being used, especially for adults, to facilitate tooth movements and reduce the duration of orthodontic treatment. The present article reports on an innovative, safe, and minimally invasive technique to perform flapless corticotomies using a dedicated surgical guide produced with a complete digital intraoral and laboratory workflow. MATERIALS AND METHODS: A 51-year-old man presented with maxillary and mandibular anterior crowding. He required rapid treatment with limited use of braces. Corticotomies were planned for both arches before the use of orthodontic appliances. The matching of the stereolithographic files obtained from the digital prints of the full arches and the cone beam computed tomography images allowed for the positioning of the cutting planes for corticisions. The guide was printed with a transparent, biocompatible, and photopolymerizable resin, and cold sterilized. Minimally invasive corticotomies were performed using a piezoelectric instrument. The orthodontic treatment started immediately after surgery. RESULTS: No adverse events were recorded during surgery. The piezoelectric instrument was guided accurately, and precise application of the corticisions prevented all the anatomical elements from being injured. The healing was uneventful and the patient experienced no pain. CONCLUSION: The present report shows that a surgical guide specifically and digitally produced for corticotomies allowed for the performance of a minimally invasive flapless technique and accurate piezosurgery. The use of such a guide was easy to implement, made the procedure safer, and reduced postoperative pain.

Clinical and radiographic changes at tissue level implants with either a machined or a modified transmucosal neck surface: A 3-year multicentre randomized controlled proof-of-concept study.

BACKGROUND: Surface modification may yield enhanced soft tissue adhesion to transmucosal titanium implant necks. AIM: To evaluate and compare changes in soft tissues around implants with a modified hydrophilic sandblasted and acid-etched neck (mSLA; test) to those with a machined neck (M; control). MATERIALS AND METHODS: Implants with a diameter of 4.1 mm and a neck height of 1.8 mm were randomly inserted in healed sites with pristine bone of the posterior maxilla or mandible. The modified Sulcus Bleeding Index (mSBI) (primary outcome) was assessed at baseline (BL) and 6, 12 and 36 months. Secondary outcomes included the assessment of pocket probing depth (PPD), mucosal recession (REC) and clinical attachment level (CAL). Standardized radiographs were taken at time of implant placement, at BL and after 12 and 36 months. RESULTS: Of the 43 randomized subjects, 38 (19 test and 19 controls) completed the 36-month follow-up. Implant survival rates amounted to 95.5% (test) and 100% (control) (p > .05). At 36 months, 77.6% of test implants and 78.9% of control implants were without any bleeding sites (mSBI = 0; p > .05). The 36-month success rate was 86.4% in the test and 85.7% in the control group, respectively (p > .05). At 36 months, the mean radiographic bone level change from BL was 0.33 ± 0.69 mm at test implants and 0.12 ± 0.3 mm at control implants (p > .05). CONCLUSION: Tissue level implants with a hydrophilic mSLA transmucosal neck failed to yield clinical and radiographic benefits compared with implants with a machined neck up to 3 years.

Change in Crown-to-Implant Ratio of Implants Placed in Grafted and Nongrafted Posterior Maxillary Sites: A 5-year Prospective Randomized Study.

PURPOSE: The aim of this study was to evaluate the performance of implants placed for 5 years in grafted vs nongrafted sinuses in relation to crown-to-implant ratio. The measurements of crown and implant lengths took into account changes in both endo-sinus and crestal bone levels over 5 years. MATERIALS AND METHODS: Enrolled patients required one or two implants in at least one sinus and presented a residual bone height of posterior maxilla ≤ 4 mm. Individual sinuses were randomly allocated either to be grafted or not before surgery. Implants of 8 mm in length were placed using osteotome sinus floor elevation (OSFE). After 10 weeks of healing, they were loaded functionally using definitive single crowns. Radiographic measurements were made on periapical radiographs taken at surgery, prosthetic steps, and 5 years. The implant length was measured between the most apical and coronal contact of bone and implant, and the crown length was measured between the most occlusal point of the crown and the crestal bone. Data were analyzed using mixed linear models. RESULTS: Twenty implants were placed in grafted sinuses and 17 in native bone (12 patients). One of the 35 restored implants failed. Immediately after surgery, the mean lengths of the implants placed in grafted and nongrafted sites were 2.4 ± 0.8 and 2.7 ± 0.9 mm, respectively (P = .351). At loading, the mean crown-to-implant ratios were 3.8 ± 0.8 and 4.6 ± 2.0 (P = .033), respectively, whereas at 5 years, they were 2.0 ± 0.8 and 2.1 ± 0.4, respectively (P = .341). CONCLUSION: The use of grafting material is not necessary to restore posterior maxilla ≤ 4 mm with OSFE and simultaneous implant placement. Over 5 years, all restored implants but one were functional. Despite unfavorable conditions in terms of initial bone anchorage and height of single crown restoration, a high initial crown-to-implant ratio did not compromise the long-term survival of implants placed in grafted or nongrafted sinuses.

Stability evaluation of implants placed in the atrophic maxilla using osteotome sinus floor elevation with and without bone grafting: A 5-year prospective study.

PURPOSE: Osteotome sinus floor elevation (OSFE) is a technique aimed at simplifying implant placement in the posterior atrophic maxilla. The necessity of bone grafting under the elevated sinus membrane has been widely debated. The aim was to compare the evolution over 5 years of implant stability in sites grafted or left ungrafted. MATERIALS AND METHODS: A total of 12 patients (9 female and 3 male) presenting ≤ 4 mm initial bone height (IBH) in the posterior maxillary sites were recruited. Implants (n = 37) were placed using OSFE. According to the randomisation, the sinuses received either bone graft (n = 20, control group) or no graft (n = 17, test group). Patients received both these treatments when both sinuses fulfilled the inclusion criteria. Control assessments were performed 1 week, 10 weeks, 12 weeks, and then 1 year, 3 years and 5 years after the implant placement. Periapical radiographs were taken and the implant stability quotient (ISQ) was measured at different time points. RESULTS: At implant surgery, the mean ISQ was 58.9 ± 11.2 for the test group and 53.8 ± 10.2 for the control group; it plummeted 10 weeks after the implant placement and rose thereafter. Five years after the implant placement, the mean ISQ reached 80.8 ± 4.2 for the control group, and 79.7 ± 4.3 for the test group. The difference between the groups was not significant. The IBH significantly affected implant stability at implant insertion and 5 years after the implant insertion, but not at the other time points. CONCLUSIONS: The implants performed using OSFE in ungrafted sites were as stable as the implants placed in grafted sites.

Osteotome Sinus Floor Elevation Without Grafting: A 10-Year Study of Cone Beam Computerized Tomography vs Periapical Radiography.

This article aims to evaluate and compare the 10-year bone anchorage and protrusion of implants into the sinus using cone beam computerized tomography (CBCT) and periapical radiography. Implants (≤ 10 mm) were placed with osteotome sinus floor elevation (OSFE) without grafting in maxillae with bone height ≤ 8 mm. After 10 years, the CBCT analysis showed bone presence at the buccal and palatal implant sides and corroborated the results obtained using periapical radiographs. In the absence of any symptom or complication, the use of two-dimensional radiography is sufficient for routine long-term follow-up of implants after OSFE without grafting.

Osteotome Sinus Floor Elevation Without Grafting: A 10-Year Clinical and Cone-Beam Sinus Assessment.

PURPOSE: To evaluate the thickness of the sinus membrane in contact with implants inserted 10 years before using an augmentation procedure without grafting material, and to identify adverse events correlated with implant protrusion in the sinus. MATERIALS AND METHODS: Osteotome sinus floor elevations were performed without grafting material. The implants (Straumann AG, Basel, Switzerland) were placed simultaneously, all protruded into the sinus. After 10 years, implants were considered viable in the absence of mobility, pain, infection, or continued radiolucency. Sinus health was assessed using cone-beam computed tomography and by the way of a questionnaire in which patients reported symptoms of sinusitis they might have had. RESULTS: Controlled implants (21 implants, 13 patients) were osseointegrated. The membrane thickness was <2 mm in 11 patients and 2 to 3 mm with flat thickening in 2 patients. No patients exhibited any clinical or radiographic signs of sinusitis. CONCLUSIONS: No sinus complications were observed after 10 years. The initial protrusion of implants into the sinus did not influence long-term sinus health. The maintenance of successful integration is thus the key to avoiding sinus complication.

Unusual Etiology and Diagnosis of Oroantral Communication due to Late Implant Failure.

Oroantral communication (OAC) rarely occurs long after implant placement. The present report describes the rare etiology and the difficulty of the diagnosis of an uncommon OAC occurring 10 years after the implant placement in the posterior maxilla. The difficulty of the diagnosis lies in the absence of clinical symptoms of sinusitis and presence of multiunit prosthesis hiding implant failure. This case report supports the need for sinus check-up during a routine implant examination.

Short implants placed with or without grafting into atrophic sinuses: the 5-year results of a prospective randomized controlled study.

OBJECTIVES: Over 5 years, (i) to evaluate the clinical efficiency of 8-mm implants placed with osteotome sinus floor elevation (OSFE) in extremely atrophic maxillae and (ii) to compare bone levels around implants placed with and without grafting. MATERIAL AND METHODS: TE® SLActive® implants (Institut Straumann AG, Basel, Switzerland) were placed in sites with a residual bone height (RBH) of ≤4 mm. Before surgery, sinuses were randomized to receive anorganic bovine bone (control) or no graft (test). After 10 weeks of healing, implants were functionally loaded with single crowns. Bone levels were measured from standardized peri-apical radiographs. RESULTS: Thirty-seven (17 test, 20 control) implants were placed in 12 patients (RBH: 2.4 ± 0.9 mm). Two early and one late failures occurred. The success rate was 91.9% (94.1% test, 90.0% control). All implants gained endo-sinus bone (3.8 ± 1.0 mm test, 4.8 ± 1.2 mm control; P = 0.004). Mean crestal bone loss (CBL) was 0.6 ± 1.1 mm, without a significant difference between the groups (P = 0.527). Mean bone gain and CBL did not change significantly between 1 and 5 years (P = 0.249 and P = 0.293, respectively). CONCLUSIONS: Atrophic posterior maxillae can be predictably rehabilitated using OSFE with a simultaneous implant placement. The new bone formed around implants after 1 year was stable after 5 years, irrespective of the presence or the absence of graft. Grafting was unnecessary to achieve an average bone augmentation of 3.8 mm, but more bone was gained with grafting.

Short Implants Placed with or without Grafting in Atrophic Sinuses: The 3-Year Results of a Prospective Randomized Controlled Study.

BACKGROUND: The question whether a minimal maxillary residual bone height (RBH) allows the predictable use of osteotome sinus floor elevation (OSFE) remains unresolved. PURPOSE: To evaluate the efficacy of short implants placed with OSFE in an RBH of ≤4 mm and to compare bone levels around implants placed with (control) or without (test) grafting after 3 years. MATERIALS AND METHODS: Eight-millimeter implants were placed by OSFE in sinuses randomized to receive anorganic bovine bone or no grafting material. Healing time before prosthetic rehabilitation was 10 weeks. Peri-implant bone levels were measured on standardized periapical radiographs. RESULTS: Thirty-seven implants (17 test, 20 control) were placed at a mean RBH of 2.4 ± 0.9 mm. Three implants failed during the 3-year follow-up. After 3 years, all implants had gained endosinus bone (test: 4.1 ± 1.0 mm; control: 5.1 ± 1.2 mm; p = .001). Mean bone gain was stable between 1 and 3 years in both groups. CONCLUSIONS: Grafting is unnecessary to achieve bone augmentation of 4.1 mm; however, more bone is gained with grafting. Bone gained over 1 year was retained. Atrophic posterior maxillae can be predictably rehabilitated using OSFE and simultaneous placement of 8-mm implants.

Osteotome Sinus Floor Elevation without Grafting: A 10-Year Prospective Study.

BACKGROUND: Little is known about the long-term outcome of implants placed in the atrophic maxilla using osteotome sinus floor elevation (OSFE) without grafting. PURPOSE: The study aims to evaluate the long-term efficiency of the procedure and stability of the peri-implant bone formed following implant placement without grafting into resorbed posterior maxilla. MATERIALS AND METHODS: Twenty-five implants (≤10 mm in length) were placed in 17 patients using OSFE without grafting. The mean residual bone height was 5.4 ± 2.3 mm. Bone levels were evaluated at 1, 3, 5, and 10 years using periapical radiographs. RESULTS: Fifteen patients (23 implants) participated in the 10-year examination. All implants fulfilled the survival criteria. Following surgery, the implant sites gained endo-sinus bone (mean: 3.0 ± 1.4 mm). The mean crestal bone loss (CBL) was limited to 1.0 ± 0.9 mm. The difference in mean endo-sinus bone gain and CBL was statistically significant between 1 and 10 years, but not between 3 and 5, 3 and 10, and 5 and 10 years. CONCLUSIONS: At 10 years, the implant survival rate was 100%. Endo-sinus bone was mainly gained during the first year. This study demonstrates the long-term predictability of OSFE without grafting and simultaneous implant placement.

Osteotome sinus floor elevation procedure for first molar single-gap implant rehabilitation: a case series.

INTRODUCTION: This case series describes single implant rehabilitation in the maxillary first molar sites. It aims to show the surgical approaches carried out versus the residual bone height (RBH) and to evaluate implant success rate and bone anchorage height after 1 year. MATERIALS AND METHODS: Placement of 10-mm-long tapered bone level implants was carried out according to the RBH: when RBH ≥10 mm, standard implant placement; when 6 mm < RBH < 10 mm, osteotome sinus floor elevation procedure (OSFE) without graft; and, when RBH ≤6 mm, OSFE with graft. RESULTS: Fourteen patients received 15 implants in a mean RBH of 5.0 ± 2.4 mm (range, 2.0-11.0 mm). One implant was placed with a standard placement technique, 4 using OSFE without graft, and 10 using OSFE with graft. The 1-year success rate was 100%, and mean bone anchorage height reached at least 9.5 mm. CONCLUSIONS: Almost all cases of maxillary single implant rehabilitation might be performed by using OSFE. In the extremely atrophic maxilla, simultaneous grafting ensures implant embedding in bone.

Paradigm shift in the management of the atrophic posterior maxilla.

When the posterior maxilla is atrophic, the reference standard of care would be to perform sinus augmentation with an autologous bone graft through the lateral approach and delayed implant placement. However, placement of short implants with the osteotome sinus floor elevation technique and without graft can be proposed for an efficient treatment of clinical cases with a maxillary residual bone height of 4 to 8 mm. The use of grafting material is recommended only when the residual bone height is ≤4 mm. Indications of the lateral sinus floor elevation are limited to cases with a residual bone height ≤ 2 mm and fused corticals, uncompleted healing of the edentulous site, and absence of flat cortical bone crest or when the patient wishes to wear a removable prosthesis during the healing period. The presented case report illustrates osteotome sinus floor elevation with and without grafting and simultaneous implant placement in extreme conditions: atrophic maxilla, short implant placement, reduced healing time, and single crown rehabilitation. After 6 years, all placed implants were functional with an endosinus bone gain.

A 5- to 6-year radiological evaluation of titanium plasma sprayed/sandblasted and acid-etched implants: results from private practice.

OBJECTIVES: This study aimed to determine bone level changes after 5-6 years of follow-up for a large group of one-stage dental implants consecutively placed in private practice. Potential confounding factors influencing crestal bone loss (CBL) were also assessed. MATERIALS AND METHODS: A total of 378 transmucosal Straumann implants in 174 patients were examined radiographically. Half of the study population (189 implants) had a titanium plasma sprayed (TPS) surface, and the other half (189 implants) were sandblasted and acid-etched (SLA). Mean CBL was measured from 5 to 6 years post-operative radiographs on the basis of known implant landmarks. Correlations of increased CBL with various independent variables were also investigated. Statistical analyses were performed using generalized estimating equations. RESULTS: Radiographic measurements showed a CBL ≤ 1.5 mm for 65% of studied implants. A CBL > 1.5 mm was found for 28% of implants, while 7% of implants had a CBL ≥ 3 mm. Three factors significantly influenced CBL (P < 0.05): implant surface texture (TPS > SLA), smoking status (smokers > non-smokers), and implant location (anterior > posterior). CONCLUSIONS: CBL was ≤1.5 mm after 5-6 years for the majority of followed implants. For implants with a CBL > 1.5 mm, statistically significant correlations were found for TPS surface type, anterior jaw locations, and smoking. Implant length did not influence CBL.

Osteotome sinus floor elevation with and without grafting material in the severely atrophic maxilla. A 1-year prospective randomized controlled study.

OBJECTIVES: (1) To measure and compare endo-sinus bone levels around implants randomly placed with an osteotome sinus floor elevation (OSFE) procedure in grafted (control) and non-grafted (test) sinuses, (2) to evaluate the OSFE efficacy with short, tapered, and chemically modified hydrophilic surfaced implants in extremely atrophic maxillae, (3) to show that fused corticals may constitute a complication risk. MATERIAL AND METHODS: The TE(®) SLActive 8 mm-long implants (Straumann AG) were placed using an OSFE procedure in 4 mm or less of bone height. Healing time before prosthetic rehabilitation was 10 weeks. One year after implant placement, bone levels were measured on standardized periapical radiographs. RESULTS: Thirty-seven (17 tests, 20 controls) implants were placed in 12 patients with a mean maxillary residual bone height (RBH) of 2.4 ± 0.9 mm. Before loading, two control implants failed (RBH 1.4 and 1.2 mm); two others rotated at loading (one test, RBH 0.9 mm; one control, RBH 1.5 mm) but were uneventfully loaded after three additional months of healing. These adverse events and complications occurred when implants were placed in merged corticals. Endo-sinus bone gain was 3.9 ± 1.0 and 5.0 ± 1.3 mm for the test and control groups (P = 0.003). The 1-year success rate was 100% and 90%, respectively (P = 0.49). CONCLUSION: Although more bone is gained when grafting material is used, this may not be required to promote endo-sinus bone gain. The OSFE procedure with or without grafting material could be efficient when the RBH is ≤ 4 mm. However, when both corticals merged, the risk of complication could increase.

Graft shrinkage and survival rate of implants after sinus floor elevation using a nanocrystalline hydroxyapatite embedded in silica gel matrix: a 1-year prospective study.

OBJECTIVES: The aims of this study were (1) to evaluate the vertical shrinkage percentage of nanocrystalline hydroxyapatite embedded in silica gel used for maxillary sinus floor elevation (SFE) and (2) to determine the survival rate of the implants 1 year after placement in the healed grafted sinuses. MATERIALS AND METHODS: Eleven maxillary sinuses were augmented in eight patients with NanoBone. After a healing period averaging 14.42 months, 19 implants were placed and followed up with clinical and radiographic evaluation. Panoramic radiographs were taken immediately after SFE and at 12 months after grafting. Measurements of changes in height were made by a computerized measuring technique using an image editing software. RESULTS: The mean graft height shrinkage percentage at 12 months after surgery was 8.84% (±5.32). One implant was lost before loading. All the 18 remaining osseointegrated implants received the prosthetic rehabilitation and were controlled after 3 months of functional loading. The implant survival rate at the 1-year interval was 94.74%. CONCLUSIONS: A 100% NanoBone alloplastic graft used in lateral SFE procedures presented limited height shrinkage. Implants placed in these grafted sinuses showed survival rates similar to those found in published data. These results should be interpreted cautiously considering the study's reduced sample size.

Esthetic outcomes with porcelain-fused-to-ceramic and all-ceramic single-implant crowns: a randomized clinical trial.

OBJECTIVES: the aim of this randomized-controlled clinical trial was to compare the objective and subjective esthetic outcomes of two types of screwed-retained single-implant crowns. MATERIALS AND METHODS: participants were randomly assigned to the test (all-ceramic) and control [porcelain-fused-to-ceramic (PFM)] groups and were seen under investigation at baseline (B), crown insertion (CI), 1-year follow-up (1Y), and 2-year follow-up (2Y). Objective parameters were assessed by an intra-oral digital photograph (1:1 ratio), a study cast, a standardized radiograph, periodontal/peri-implant measurements, and questionnaires were obtained for the subjective parameters. In addition, pink esthetic score (PES) and white esthetic score (WES) were calculated for both groups. For the subjective evaluation, a visual analogue scale (VAS) questionnaire was used to assess the level of patient satisfaction regarding the esthetic outcome. Then, nine expert clinicians visually inspected and assessed subjective evaluation at the professional level. Statistical analysis was used to compare between groups and investigational appointments. RESULTS: twenty patients were included in the study, 10 allocated to the all-ceramic group and 10 to the PFM group. No statistically significant differences were observed for the objective measurements comparing the test and control groups. Minor chipping of the ceramic veneering material was observed in the two patients of control group. The mean difference for all groups comparing objective parameters revealed an increase of papilla height between time points. A slight recession (0.26 mm) of the peri-implant mucosal margin at the implant site was observed between 1Y and 2Y. Mean values for PES and WES were 13.9 and 13.1 for the PFM group and for the all-ceramic group, respectively. These values were not statistically significant. Implant crown volume, outline, translucency, and characterization showed major discrepancies with the contra-lateral natural teeth. As for subjective parameters, VAS patients' responses regarding their perceptions of the esthetic outcome showed no statistical differences between groups and clinicians' accuracy scores were 50% and 47% for PFM and all-ceramic crowns, respectively. CONCLUSION: PFM and all-ceramic single-implant restorations may be indistinguishable from each other regarding the objective/subjective assessment of esthetic integration. The material chosen for fabricating an implant crown per se does not ensure an optimal esthetic outcome if other esthetic parameters are not present.

Osteotome sinus floor elevation technique without grafting: a 5-year prospective study.

AIM: To evaluate the long-term stability of peri-implant bone formation following implant placement without grafting into resorbed posterior maxillae. MATERIALS AND METHODS: Twenty-five implants of 10 mm were placed in 17 patients to rehabilitate atrophic maxillae by means of an osteotome sinus floor elevation (OSFE) procedure without grafting. Mean residual bone height was 5.4±2.3mm. Bone levels were evaluated at 1, 3 and 5 years using periapical radiographs. RESULTS: All implants fulfilled survival criteria and gained peri-implant bone (mean increase 3.2±1.3mm). Implant protrusion into the sinus decreased from 4.9±1.9mm after surgery to 1.5±0.9mm after 5 years. Mean crestal bone loss amounting to 0.8±0.8mm stabilized over the 5-year observation interval. Twenty implants showed additional peri-implant bone gain following the 1-year control. CONCLUSIONS: Implant rehabilitation of atrophic maxillae may be greatly simplified using implants 10mm and the OSFE technique without grafting. Grafting material is not needed to gain at least 3mm of bone in the atrophic maxilla. The procedure appears predictable with favourable long-term results.

Placement of tapered implants using an osteotome sinus floor elevation technique without bone grafting: 1-year results.

PURPOSE: Achieving implant primary stability in poor-density bone is difficult when the available bone height is less than 6 mm. This study assesses the 1-year clinical performance of tapered implants in sites of reduced height in combination with osteotome sinus floor elevation without bone grafting material. MATERIALS AND METHODS: An osteotome sinus floor elevation procedure without grafting material was performed in the atrophic posterior maxilla. Tapered implants were placed in maxillary sites with residual bone height of 1 to 6 mm. Implant primary stability was assessed by finger pressure exerted on the implant. Bone gain in the elevated sinus and crestal bone loss were evaluated at 1 year via radiographs. RESULTS: Fifty-four tapered implants were placed in 32 patients and were loaded after a mean of 4.2 +/- 1.6 months. The mean maxillary residual bone height was 3.8 +/- 1.2 mm. All implants achieved primary stability, and all were successfully loaded. At the 1-year radiographic control, the mean bone gain within the sinus was 2.5 +/- 1.7 mm and the mean crestal bone loss was 0.2 +/- 0.8 mm. CONCLUSIONS: In the atrophic posterior maxilla, primary stability can readily be achieved with tapered implants, even when the mean residual bone height is 3.8 mm. Despite limited bone support and lack of grafting material, all loaded implants were clinically stable, and crestal bone loss was limited. A net bone gain of 2.3 +/- 1.8 mm was observed. Survival and success rates were 100% and 94.4%, respectively. Elevation of the sinus membrane without the addition of bone grafting material led to bone formation beyond the original limit of the sinus floor.

Osteotome sinus floor elevation technique without grafting material and immediate implant placement in atrophic posterior maxilla: report of 2 cases.

PURPOSE: This case report discusses 2 patients who required implant placement in the atrophic posterior maxilla to support a fixed prosthesis with the least invasive and shortest procedure. MATERIALS AND METHODS: The reference standard of care would be to perform sinus augmentation with an autologous bone graft through the lateral approach with delayed implant placement. However, in these cases, the posterior maxillas were treated with an osteotome sinus floor elevation procedure without grafting material and simultaneous placement of short, 8- and 10-mm-long, tapered implants. RESULTS: All implants achieved primary stability and were successfully loaded after 3.6 months of healing. At the 1- and 2-year follow-up visits, they were clinically stable and the final prostheses were functioning. The mean endosinus bone gain was 5.1 +/- 1.3 mm. In 1 of the patients, the implants were completely embedded in the newly formed bone and the sinus floor had been relocated apical to its previous demarcation. CONCLUSIONS: The findings from these 2 cases suggest that the osteotome sinus floor elevation procedure without grafting material, and immediate placement of tapered implants, might be applied in situations for which previously only the lateral approach was considered (at the condition that implants achieve firm primary stability). More patients and longer follow-up are warranted to investigate how reliable this technique can be when applied to the atrophic maxilla.